NCT06553287 - Safety, Tolerability and Pharmacokinetics of LNK01004 Ointment in Adults With Atopic Dermatitis. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 12, 2023

Primary Completion Date

June 18, 2024

Study Completion Date

June 18, 2024

Conditions

Atopic Dermatitis

Interventions

DRUG

LNK01004 ointment 0.3%

LNK01004 ointment 0.3% for topical application

DRUG

LNK01004 ointment 1.0%

LNK01004 ointment 1.0% for topical application

DRUG

LNK01004 ointment 1.5%

LNK01004 ointment 1.5% for topical application

DRUG

Vehicle BID

Inactive vehicle matched to LNK01004 ointment for topical application.

Trial Locations (1)

Hospital for skin diseases, Institute of Dermatology, Chinese Academy of Medical Sciences., Nanjing